- Info
- Portfolio
- Significant Ownership
- Insider Ownership
- Financials
- Holders: GSK, G3910J179
Significant Ownership of GSK plc
- Signature - Title
- /s/ Victoria A. Whyte - Victoria A. Whyte, Authorized Signatory
- Location
- London
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by GSK plc.
Follow Filing Activity
Follow GSK plc and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of GSK plc
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| SPRO | SPERO THERAPEUTICS, INC. | Common Stock, Par Value $0.001 | 16% | $6,709,142 | 9,190,606 | GSK PLC | 27 Mar 2025 | ||
| CVAC | CureVac N.V. | Common Shares, par value (euro) 0.12 per share | 0% | $0 | -$87,937,266 | 0 | -100% | GSK plc | 03 Dec 2025 |
Schedules 13D/G Reported by GSK plc:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.